US Patent 9611265 Tropomyosin-related kinase (TRK) inhibitors
Patent 9611265 was granted and assigned to Genzyme on April, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9611265 Tropomyosin-related kinase (TRK) inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
